🧬

Age & Use Verification

You must be 21+ to enter this site.

All products discussed on this site are Research Use Only (RUO) compounds intended strictly for laboratory research. Nothing here is medical advice, and these products are not for human or veterinary use.

Exit

We use cookies for analytics and to improve your experience. See our disclosure.

Cagrilintide: Research Profile, Dosages & Supplier Prices

Amylin analog · Lyophilized vial (research) · Also known as: AM833, CagriSema component (with semaglutide)

Cagrilintide is a amylin analog compound with a molecular weight of ~4400 g/mol and a research half-life of extended (~week) via fatty acid albumin binding in published research. Cagrilintide is a long-acting amylin receptor agonist peptide developed by Novo Nordisk. It is the second component of CagriSema (cagrilintide + semaglutide), which has published phase 2/3 data showing weight reduction beyond semaglutide alone.

Research Use Only (RUO). Not for human or veterinary use. Not medical advice.

SequenceAmylin analog with fatty acid modification (structure published in trial literature)
FormulaC194H312N54O59S2 (approximate, modified amylin analog)
Mol. weight~4400 g/mol
Half-lifeExtended (~week) via fatty acid albumin binding in published research
Forms soldLyophilized vial (research)

What is Cagrilintide?

Research interest covers amylin receptor pharmacology, satiety signaling, and combination incretin-amylin mechanisms. Amylin analogs are a distinct mechanism from GLP-1 agonists, which makes cagrilintide a key research target for combination metabolic studies.

Cagrilintide is a complex modified peptide with real synthesis cost. Verify third-party mass spec identity on every batch.

Mechanism of Action (Research Context)

Amylin and calcitonin receptor agonist studied for satiety signaling and gastric emptying modulation, with fatty-acid-mediated albumin binding for weekly dosing.

Research Areas

Amylin pharmacologySatiety signalingCombination metabolic research

Cagrilintide Dosages in Research

5mg10mg

Published clinical research titrated once-weekly doses up to 4.5mg in human trials. Laboratory research use only.

Dosage information is a summary of published laboratory research and is provided for informational purposes only. These compounds are not for human use.

Storage & Handling

Lyophilized: -20C. Reconstituted: 2-8C, use within 30 days.

Cagrilintide Supplier Price Comparison

SupplierProductPriceScore
Research Peptides For Sale Online Cagrilintide $107.99 ★ 2.1
Certified Pep CAGRILINTIDE 10MG 10mg $128.00 ★ 9.8
Certified Pep GLP3-R / CAGRI 12.5/2.5 MG 12.5/2.5 MG $200.00 ★ 9.8

Cagrilintide FAQ

CagriSema is the investigational combination of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist), which published trials showed produces greater weight reduction than either component alone.
🧬

Before you go —

Get weekly supplier alerts, price-drop notifications, and COA updates. Plus our featured pick: Certified Pep.